S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

ProShares Ultra Health Care Stock Forecast, Price & News

-0.79 (-0.79%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
9,977 shs
Average Volume
14,841 shs
Market Capitalization
$154.49 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive RXL News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Health Care and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares Ultra Health Care
Tax ClassificationRegulated Investment Company
Inception Date1/30/2007
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Healthcare Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$155.75 million
Average Daily Volume$5.54 thousand

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Lead Market MakerIMC Chicago

ProShares Ultra Health Care (NYSEARCA:RXL) Frequently Asked Questions

How has ProShares Ultra Health Care's stock price been impacted by COVID-19 (Coronavirus)?

ProShares Ultra Health Care's stock was trading at $100.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RXL stock has decreased by 0.9% and is now trading at $99.67.
View which stocks have been most impacted by COVID-19

Is ProShares Ultra Health Care a good dividend stock?

ProShares Ultra Health Care pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.10%.
View ProShares Ultra Health Care's dividend history.

Who are ProShares Ultra Health Care's key executives?

ProShares Ultra Health Care's management team includes the following people:
  • Michael L. Sapir, Chairman of ProShares Trust (Age 57)
  • Louis M. Mayberg, President of ProShares Trust (Age 53)
  • Victor M. Frye Esq., Chief Compliance Officer and AML Officer of ProShares Trust (Age 56)
  • Simon D. Collier, Treasurer of ProShares Trust (Age 51)
  • Gary A. Casagrande, Assistant Treasurer of ProShares Trust (Age 40)
  • Charles S. Todd, Assistant Treasurer of ProShares Trust (Age 41)
  • Stephenie Adams, Acting Secretary of ProShares Trust (Age 43)
  • Gregory Pickard Esq., Assistant Secretary of ProShares Trust (Age 48)
  • Russell S. Reynolds III, Trustee of ProShares Trust (Age 55)
  • Michael C. Wachs, Trustee of ProShares Trust (Age 51)

What other stocks do shareholders of ProShares Ultra Health Care own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Health Care investors own include American Express (AXP), Mastercard (MA), Markel (MKL), NVIDIA (NVDA), PayPal (PYPL), Adobe (ADBE), Arista Networks (ANET), Alibaba Group (BABA), Berkshire Hathaway (BRK.B) and ProShares Ultra Technology (ROM).

What is ProShares Ultra Health Care's stock symbol?

ProShares Ultra Health Care trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "RXL."

Who are ProShares Ultra Health Care's major shareholders?

ProShares Ultra Health Care's stock is owned by a number of retail and institutional investors. Top institutional shareholders include IMC Chicago LLC (1.40%), Advisor Group Holdings Inc. (1.32%), Citadel Advisors LLC (1.01%), OLD Mission Capital LLC (0.41%), Koshinski Asset Management Inc. (0.03%) and Newbridge Financial Services Group Inc. (0.03%).

Which major investors are selling ProShares Ultra Health Care stock?

RXL stock was sold by a variety of institutional investors in the last quarter, including OLD Mission Capital LLC, and Advisor Group Holdings Inc..

Which major investors are buying ProShares Ultra Health Care stock?

RXL stock was acquired by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, IMC Chicago LLC, Koshinski Asset Management Inc., Newbridge Financial Services Group Inc., and BNP Paribas Arbitrage SA.

How do I buy shares of ProShares Ultra Health Care?

Shares of RXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares Ultra Health Care's stock price today?

One share of RXL stock can currently be purchased for approximately $99.67.

How much money does ProShares Ultra Health Care make?

ProShares Ultra Health Care has a market capitalization of $154.49 million.

What is ProShares Ultra Health Care's official website?

The official website for ProShares Ultra Health Care is www.proshares.com.

Where are ProShares Ultra Health Care's headquarters?

How can I contact ProShares Ultra Health Care?

ProShares Ultra Health Care's mailing address is 7501 Wisconsin Avenue Suite 1000 - East Tower, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.